CN100382839C - Chinese-medicinal composition for treating coronary heart disease - Google Patents
Chinese-medicinal composition for treating coronary heart disease Download PDFInfo
- Publication number
- CN100382839C CN100382839C CNB2006100101652A CN200610010165A CN100382839C CN 100382839 C CN100382839 C CN 100382839C CN B2006100101652 A CNB2006100101652 A CN B2006100101652A CN 200610010165 A CN200610010165 A CN 200610010165A CN 100382839 C CN100382839 C CN 100382839C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
A Chinese medicine for treating coronary heart disease is prepared from 20 Chinese-medicinal materials including ginseng, notoginseng, Chinese angelica root, red sage root, etc.
Description
One, technical field:
What the present invention relates to is Chinese medicine composition, particularly a kind of Chinese medicine composition for the treatment of coronary heart disease.
Two, background technology:
Coronary heart disease belongs to cardiovascular disease, is higher a kind of common, the frequently-occurring disease of present sickness rate, the trend that progressively rises is arranged in recent years, the serious physical and mental health that is threatening people.Coronary heart disease is sick damage of heart itself and a kind of illness of causing, and its clinical manifestation is sensation of oppression over the chest with shortness of breath, pain of the heart area, arrhythmia, rhythm of the heart failure when serious, and electrocardiogram equipment shows that the T ripple changes, cardiac blood supply deficiency.The cause of coronary heart disease reason is comparatively complicated, and, pathological changes aging with the bodily fuctions and people self emotion, diet, daily life and residing environment are closely related.Differential diagnosis in tcm thinks to be due to depression, the stagnation of QI, blood stasis, the deficiency of heart-QI.Nurse one's health for coronary heart disease treatment at present western medicine or the Chinese medicines of adopting more.Western medicine, side effect is bigger, and is on the high side, and cures the symptoms, not the disease; The treatment by Chinese herbs medicine has multiple as SHANHAI PILL, FUFANG DANSHEN PIAN or drop pill, the prescription of these medicines has single agent, and compositions is also arranged, though each has something to recommend him, but deficiency is arranged respectively also, for example, SHANHAI PILL adopts the theoretical point view that nourishes blood with blood in the theory of Chinese medical science and establishes, better to treatment blood-deficiency type coronary heart disease curative effect, but treat various types of coronary heart disease with it, curative effect is also not exclusively satisfied, and price is very expensive.
Three, summary of the invention:
The objective of the invention is at the problems referred to above, a kind of Chinese medicine composition for the treatment of coronary heart disease is provided, this medicament composing prescription has no side effect at depression, the stagnation of QI, blood stasis, deficiency of heart-QI and the coronary heart disease that causes is evident in efficacy, and cost is low.
The technical solution adopted for the present invention to solve the technical problems is: a kind of raw medicinal material for the treatment of the Chinese medicine composition of coronary heart disease is Radix Ginseng, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Radix Notoginseng, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Curcumae, Olibanum, Sanguis Draxonis, the Radix Astragali, Radix Glycyrrhizae, succinum, Rhizoma Acori Graminei, Cinnabaris, Lignum Dalbergiae Odoriferae, Styrax, Benzoinum, Lignum Santali Albi, Borneolum Syntheticum; Each raw medicinal material content is counted by weight in the prescription: Radix Ginseng 8-12 part, Radix Ophiopogonis 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Radix Notoginseng 8-12 part, Radix Angelicae Sinensis 10-20 part, Radix Salviae Miltiorrhizae 16-30 part, Rhizoma Chuanxiong 12-16 part, Radix Curcumae 8-12 part, Olibanum 4-8 part, Sanguis Draxonis 4-8 part, Radix Astragali 20-40, Radix Glycyrrhizae 8-12 part, succinum 8-12 part, Rhizoma Acori Graminei 4-8 part, Cinnabaris 2-4 part, Lignum Dalbergiae Odoriferae 4-6 part, Styrax 6-8 part, Benzoinum 4-6 part, Lignum Santali Albi 4-6 part, Borneolum Syntheticum 2-4 part.
Above-mentioned prescription is a monarch drug with Radix Ginseng, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Radix Notoginseng, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Sanguis Draxonis, Olibanum, Rhizoma Chuanxiong, Radix Curcumae, and it mainly acts on is the gas of enriching blood, promoting blood circulation to restore menstrual flow, promoting the circulation of QI to relieve pain, removing blood stasis and activating blood flow; With Lignum Dalbergiae Odoriferae, Styrax, Benzoinum, Lignum Santali Albi, Borneolum Syntheticum is accessory drugs, is used for the turbid descending gas, and the stasis of blood of dehematizing, is reduced phlegm at inducing resuscitation, to strengthen regulating the flow of QI to promote menstrual discharge, blood-activating analgetic; Succinum, Rhizoma Acori Graminei, Cinnabaris are left medicine, and it mainly acts on is tranquillizing and allaying excitement, and dissolving turbid damp, not change the breast that causes vexed; The Radix Astragali, Radix Glycyrrhizae are messenger drug, invigorating QI to consolidate the body surface resistance, priming return through.Blood circulation promoting and blood stasis dispelling is played in above-mentioned drug matching jointly, regulating QI to relieve pain, dredge the meridian passage, the effect of tranquillizing and allaying excitement is used for the treatment of coronary heart disease, can obviously improve myocardial ischemia, ischemia, strengthens blood supply of cardiac muscle, improve the cardiac muscle circulation, improve myocardium ability, enhancing immunity, eliminating pathogenic factor for supporting vital QI.This Chinese medicine preparation reasonable recipe has no side effect, and is easy to make.
With above-mentioned 20 flavor Chinese medicines is raw material, sieves through levigation, and mix homogeneously is made the watered pill, honeyed pill, tablet, powder, capsule.
The instructions about how to take medicine consumption: every day 2～3 times, once oral 3g is grown up.
Taboo: diet Radix Raphani.
Advantage that the present invention has and good effect: this medicament composing prescription has QI invigorating, allays excitement, the chest stuffiness relieving is regulated the flow of vital energy, the effect of blood circulation promoting and blood stasis dispelling, coronary circulation-promoting pain-relieving, can treat depression, the stagnation of QI, blood stasis, deficiency of heart-QI and the coronary heart disease that causes, and have no side effect, and cost is low.Clinical trail investigation after the patient takes, this Chinese medicine composition good effect, instant effect, general medication took effect about 3～5 days, makes great progress about 7～10 days, be more than 95% with the back total effective rate.
Four, the specific embodiment
The invention will be further described below in conjunction with specific embodiment.
Embodiment: the weight of Chinese medicine composition and component content are as follows:
Radix Ginseng 10 parts (50g), Radix Ophiopogonis 10 parts of (50g), Fructus Schisandrae Chinensis 10 parts of (50g), Radix Notoginseng 10 parts of (50g), Radix Angelicae Sinensis 20 parts of (100g), Radix Salviae Miltiorrhizae 20 parts of (100g), Rhizoma Chuanxiong 15 parts of (75g), Radix Curcumae 10 parts of (50g), Olibanum 6 parts of (30g), Sanguis Draxonis 6 parts of (30g), the Radix Astragali 30 parts of (150g), Radix Glycyrrhizae 10 parts of (50g), succinum 10 parts of (50g), Rhizoma Acori Graminei 6 parts of (30g), Cinnabaris 3 parts of (15g), Lignum Dalbergiae Odoriferae 5 parts of (25g), Styrax 7 parts of (35g), Benzoinum 5 parts of (25g), Lignum Santali Albi 5 parts of (25g), 3 parts of Borneolum Syntheticums (15g), totally 20 flavor Chinese medicines.
Adopt Chinese medicine composition of the present invention, treatment coronary heart disease through clinical practice in 2 years, and is carried out tracing observation to 80 people wherein, instant effect, and good effect does not recur.
Practical case 80 examples, wherein the male is 48 people, at 50～68 years old age, accounts for 60%; The women is 32 people, and the age is 45～65 years old, accounts for 40%, it is longer to be sick time, through after taking multiple Drug therapy, and slow curative effect or frequent recurrence person more, show as depression, the stagnation of QI, blood stasis, deficiency of heart-QI, symptom is a sensation of oppression over the chest with shortness of breath, angina pectoris, lassitude and weak, irregularly intermittent and regularly intermittent pulse, vexed not peaceful, puffiness of face, arrhythmia etc.Clinical effectiveness: before taking Chinese medicine composition of the present invention, Electrocardioscopy T ripple falls to be worth, and sinus rhythm all exists; By every day 3 times, each 3 gram dosage are taken this medicine, after 3～5 days, and male 44 people, women 24 people take effect, and the above-mentioned abnormal electrocardiogram of Electrocardioscopy has clear improvement; Same dose and instructions about how to take medicine, 6～15 days, male 46 people, women 26 people make great progress; Take 30～60 days persons, male 48 people, women 28 people reach and cure or basic the healing, and Electrocardioscopy is normal ECG.Visit the patient after 12 months, 52 routine male 38 people, women 14 people are healed entirely, and basic complete more patient also has 25 examples, male 10 people, women 18 people.Sensation of oppression over the chest with shortness of breath, angina pectoris, lassitude and weak, irregularly intermittent and regularly intermittent pulse, vexed not peaceful, puffiness of face, symptoms such as arrhythmia have disappeared, and the patient obviously is tending towards normally, and total effective rate is more than 95%.
Claims (3)
1. Chinese medicine composition for the treatment of coronary heart disease, it is characterized in that: the raw medicinal material of this Chinese medicine composition is Radix Ginseng, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Radix Notoginseng, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Curcumae, Olibanum, Sanguis Draxonis, the Radix Astragali, Radix Glycyrrhizae, succinum, Rhizoma Acori Graminei, Cinnabaris, Lignum Dalbergiae Odoriferae, Styrax, Benzoinum, Lignum Santali Albi, Borneolum Syntheticum; Each constituent content is counted by weight in the prescription: Radix Ginseng 8-12 part, Radix Ophiopogonis 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Radix Notoginseng 8-12 part, Radix Angelicae Sinensis 10-20 part, Radix Salviae Miltiorrhizae 16-30 part, Rhizoma Chuanxiong 12-16 part, Radix Curcumae 8-12 part, Olibanum 4-8 part, Sanguis Draxonis 4-8 part, Radix Astragali 20-40 part, Radix Glycyrrhizae 8-12 part, succinum 8-12 part, Rhizoma Acori Graminei 4-8 part, Cinnabaris 2-4 part, Lignum Dalbergiae Odoriferae 4-6 part, Styrax 6-8 part, Benzoinum 4-6 part, Lignum Santali Albi 4-6 part, Borneolum Syntheticum 2-4 part.
2. the Chinese medicine composition of treatment coronary heart disease according to claim 1 is characterized in that: each raw medicinal material content is 10 parts of Radix Ginsengs, 10 parts of Radix Ophiopogonis, 10 parts of Fructus Schisandrae Chinensis, 10 parts of Radix Notoginseng, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Rhizoma Chuanxiongs, 10 parts of Radix Curcumaes, 6 parts of Olibanums, 6 parts of Sanguis Draxonis, 30 parts of the Radixs Astragali, 10 parts in Radix Glycyrrhizae, 10 parts of succinums, 6 parts of Rhizoma Acori Graminei, 3 parts in Cinnabaris, 5 parts of Lignum Dalbergiae Odoriferaes, 7 parts of Styrax, 5 parts of Benzoinumes, 5 parts in Lignum Santali Albi, 3 parts of Borneolum Syntheticums in the described prescription.
3. the Chinese medicine composition of treatment coronary heart disease according to claim 1 and 2 is characterized in that: the dosage form of described Chinese medicine composition is the watered pill, honeyed pill, tablet, powder or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100101652A CN100382839C (en) | 2006-06-13 | 2006-06-13 | Chinese-medicinal composition for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100101652A CN100382839C (en) | 2006-06-13 | 2006-06-13 | Chinese-medicinal composition for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1895620A CN1895620A (en) | 2007-01-17 |
| CN100382839C true CN100382839C (en) | 2008-04-23 |
Family
ID=37608362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100101652A Expired - Fee Related CN100382839C (en) | 2006-06-13 | 2006-06-13 | Chinese-medicinal composition for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100382839C (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101244122B (en) * | 2008-03-04 | 2012-01-25 | 涿州东乐制药有限公司 | Pharmaceutical combination |
| CN101628032B (en) * | 2009-08-18 | 2011-07-27 | 广东八加一医药有限公司 | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| CN102133332B (en) * | 2011-03-21 | 2012-07-25 | 承德医学院中药研究所 | Traditional Chinese medicine compound preparation for preventing and curing coronary heart disease and angina and preparation method thereof |
| CN102423457B (en) * | 2011-12-08 | 2013-07-24 | 刘智中 | Traditional Chinese medicine capsules for treating coronary heart disease |
| CN103239083A (en) * | 2013-05-21 | 2013-08-14 | 海安添鑫丝业有限公司 | Silk quilt with coronary-disease preventive sachets |
| CN103784888A (en) * | 2014-02-23 | 2014-05-14 | 曹小松 | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis |
| CN104800772A (en) * | 2015-05-08 | 2015-07-29 | 康莉 | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition |
| CN105641399A (en) * | 2015-12-23 | 2016-06-08 | 夏京奎 | Traditional Chinese medicine alternative to bypass or stent |
| CN107184760B (en) * | 2017-06-06 | 2020-09-29 | 黑龙江中医药大学 | Chinese medicinal composition for treating cardiovascular diseases and preparation method thereof |
| CN108295216A (en) * | 2018-02-26 | 2018-07-20 | 李天明 | One kind is for treating cardiopathic drug and preparation method thereof |
| CN108524872A (en) * | 2018-06-13 | 2018-09-14 | 杨万彬 | A kind of Chinese medicine preparation for treating coronary heart disease |
| CN109602866A (en) * | 2019-01-31 | 2019-04-12 | 舒虹 | A kind of Chinese medicine composition that treating coronary heart disease, preparation, preparation method and applications |
| CN110339326A (en) * | 2019-08-29 | 2019-10-18 | 朱江 | A kind of logical heart ball of stilbene deer |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1224614A (en) * | 1998-01-24 | 1999-08-04 | 倪德贵 | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation |
-
2006
- 2006-06-13 CN CNB2006100101652A patent/CN100382839C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1224614A (en) * | 1998-01-24 | 1999-08-04 | 倪德贵 | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1895620A (en) | 2007-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN101612349B (en) | Medicine for treating coronary heart disease | |
| CN101843661A (en) | Chinese medicament for treating angina | |
| CN100455313C (en) | Chinese medicine for treating cardiovascular and cerebrovascular disease | |
| CN106474356A (en) | A kind of medicine of logical stalkization bolt and preparation method thereof | |
| CN103393749A (en) | Traditional Chinese medicine for preventing and treating ischemic cardiovascular and cerebrovascular diseases | |
| CN100398139C (en) | Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof | |
| CN101024048A (en) | Medicine for treating heart disease | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN102579804B (en) | Chinese medicine for treating stenocardia | |
| CN102552715B (en) | Chinese medicinal composition, medicine containing Chinese medicinal composition and preparation method of medicine | |
| CN101991829B (en) | Medicament for treating stomach illness | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN104352810A (en) | Medicine for treating palpitation and preparation method thereof | |
| CN103127413B (en) | Pharmaceutical preparation for treating coronary diseases | |
| CN102836320B (en) | Chinese medicinal pill for treating tachyarrhythmia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN1242198A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN101773590A (en) | Chinese drug capsule for treatment of coronary heart disease with qi deficiency and blood stasis | |
| CN100594914C (en) | Medicine for curing coronary heart disease | |
| CN101396468B (en) | Traditional Chinese medicine for treating diabetes coronary heart disease | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN1201802C (en) | Coronary heart disease treating Chinese herbal medicine capsule | |
| CN103191326B (en) | Medicine preparation for treating coronary heart diseases | |
| CN101461875B (en) | Chinese medicinal composition for treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080423 Termination date: 20190613 |